Diagnostic and Interventional Cardiology

Complications during procedures only contributed to death in about 20% of cases

Around 10% of Deaths from Coronary Stenting, Balloon Angioplasty are Preventable

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

April 16, 2024

Investigational technology designed for patients undergoing emerging large bore percutaneous catheter-based venous interventional procedures

News | Vascular Closure Devices

Vivasure Medical Announces First Large Hole Venous Patient Treated with PerQseal Elite Vascular Closure System

April 16, 2024 — Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel ...

April 16, 2024

News | Cardiovascular Clinical Studies

CVRx Announces Availability of Additional Data Supporting Long-term Benefits of Barostim

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

April 16, 2024

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Abbott/Thoratec Corp. is recalling HeartMate II and HeartMate 3 Left Ventricular Assist System (LVAS) due to an issue called Extrinsic Outflow Graft Obstruction, (EOGO).

News | FDA

FDA Announces Recalls of Abbott/Thoratec Corp. Heartmate II and Heartmate 3 Left Ventricular Assist System (LVAS) Due to Long-term Buildup of biological material Causing an Obstruction

April 15, 2024 — The U.S. Food and Drug Administration (FDA) announced Abbott/Thoratec Corp. is recalling HeartMate II ...

April 15, 2024

The Acolyte System is intended to provide interventional cardiologists with a more reliable and predictable tool to facilitate revascularization of chronic total occlusion (CTO)

News | FDA

Simpson Interventions Receives FDA Breakthrough Device Designation for Acolyte Image Guided Crossing and Re-Entry Catheter System

April 12, 2024 — Simpson Interventions, Inc., a pioneering medical technology company specializing in cardiovascular ...

April 12, 2024

New Data Presented at the European Heart Rhythm Association Conference Marks First Scientific Presentation on HeartBeam AI, the Company’s Deep Learning Technology

News | Wearables

HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias

April 12, 2024 — HeartBeam, Inc., a medical technology company focused on transforming cardiac care through the power of ...

April 12, 2024

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that contributes to the greater incidence of heart failure in men.

News | Heart Failure

New Advance Against a Form of Heart Failure Prevalent in Men

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

April 12, 2024

Trial bolsters evidence that less invasive strategy is safe and effective in younger, lower-risk patients

News | Cardiovascular Clinical Studies

TAVR Found Non-Inferior to SAVR for Low-Risk Patients

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

April 11, 2024

Results from the IVUS-DCB trial were recently presented at the American College of Cardiology Annual Scientific Session, ACC.24.

News | ACC

Intravascular Ultrasound Outperforms Angiography for Peripheral Artery Disease Treatment

April 11, 2024 — One-year success rates from angioplasty procedures to open clogged arteries in the legs were ...

April 11, 2024

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

PCI shows substantial benefits over medications alone

News | Cardiovascular Clinical Studies

Preventive Percutaneous Coronary Intervention for High-Risk Coronary Plaques Reduces Cardiac Events

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

April 11, 2024

AMA survey finds economic, patient-care impact of Change Healthcare cyber-attack ongoing

News | Cybersecurity

Life After Change Cyber-attack: Without Payment for Claims, Physicians Struggle to Keep Practices Afloat

April 10, 2024 — The American Medical Association (AMA) released informal survey findings (PDF) showing the ongoing ...

April 10, 2024

A new technology using ultralow temperature cryoablation (ULTC), developed by Adagio Medical, has eliminated clinical ventricular tachycardia (VT) in 94% of patients. The late-breaking science was presented this week during EHRA 2024, a scientific congress of the European Society of Cardiology (ESC).

News | ESC

Cryocure-VT Trial Outcomes Presented in EHRA 2024 Late-Breaking Science Session

April 10, 2024 — A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular ...

April 10, 2024

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.

News | ESC

News from EHRA 2024: International Experts Agree on Standards for Catheter Ablation of Atrial Fibrillation

April 10, 2024 — An international consensus statement on how to treat atrial fibrillation with catheter or surgical ...

April 10, 2024

Study found no difference in troponin biomarkers up to one month after anthracycline treatment

News | Cardiovascular Clinical Studies

ACE Inhibitor Not Protective Against Heart Damage from Chemotherapy

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

April 09, 2024

Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as the organization’s first non-physician president.

News | Cardiovascular Business

Cathie Biga is New American College of Cardiology President

April 9, 2024 — Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as ...

April 09, 2024